FFA
UTHR icon

Founders Financial Alliance’s United Therapeutics UTHR Stock Holding History

Founders Financial Alliance’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29
Closed -$3K – 1206
2020
Q3 		$3K Buy
+29
New +$3.18K ﹤0.01% 1163

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Founders Financial Alliance's UTHR Position: Q4 2020 in Review

Founders Financial Alliance sold out of United Therapeutics (UTHR) in Q4 2020, closing a stake of 29 shares — an estimated $3K sold.

Founders Financial Alliance first reported a position in UTHR in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 356 funds tracked by Wall St. Rank hold UTHR as of Q4 2020.

  • Founders Financial Alliance reported no remaining United Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 29 United Therapeutics shares in Q4 2020, an estimated $3K.
  • Founders Financial Alliance first reported a position in United Therapeutics in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's United Therapeutics position peaked at $3K in Q3 2020.
  • 356 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.